Changes in the Eradication Rate of Conventional Triple Therapy for Helicobacter pylori Infection in Korea / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 141-145, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-89372
ABSTRACT
Although, the prevalence of Helicobacter pylori infection in Korea has declined owing to the eradication therapy, recent seroprevalence of H. pylori infection is still reported to be as high as 54.4%. Until now, "standard regimen" for eradication of H. pylori has been conventional triple therapy consisting of proton pump inhibitor, amoxicillin, and clarithromycin. However, with the increase in antibiotic resistance, especially against clarithromycin, the eradication rate of conventional triple therapy has steadily declined during the past 13 years in Korea. Present eradication rate of standard triple therapy is reported to be less than 80%, which is the Maginot line of efficacy for the currently available regimen. Therefore, new first line eradication regimen is needed to enhance the eradication rate of H. pylori infection.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Esquema de Medicación
/
Helicobacter pylori
/
Infecciones por Helicobacter
/
Claritromicina
/
Pueblo Asiatico
/
Quimioterapia Combinada
/
Inhibidores de la Bomba de Protones
/
República de Corea
/
Erradicación de la Enfermedad
/
Amoxicilina
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
The Korean Journal of Gastroenterology
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS